logo-loader

SFA Therapeutics

Receive alerts
Market:
PRIVATE
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease-- the use of microbiome-derived metabolites as drugs